MedTrace Logo

The Effect Of Methylphenıdate Treatment On Neuroınflammatıon Levels In Chıldren Wıth Attentıon Defıcıt Hyperactıvıty Dısorder

NCT07041333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2026-02-24

Study results available
· View outcomes & findings →

Summary

The aim of this study was to investigate the effect of treatment of ADHD with methylphenidate on neuroinflammation by examining the levels of Interleukin-6 (IL-6), S100B, Claudin-5 in serum samples of patients who were diagnosed with attention deficit hyperactivity disorder (ADHD) and started or planned to start methylphenidate for treatment as per routine, at month 0 before the initiation of methylphenidate treatment and at month 3 after the initiation of treatment.

Conditions

  • Attention Deficit Disorder With Hyperactivity (ADHD)

Sponsors & Collaborators

  • Enes Faruk ALTUNKILIÇ

    lead OTHER

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-14
Primary Completion
2025-10-19
Completion
2025-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07041333 on ClinicalTrials.gov